%0 Journal Article
%T Non-invasive glioblastoma immunoprofiling by printed peptide arrays
%A Andreas Mock
%A Christel Herold-Mende
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2015.1069941
%X Immune monitoring assays for patient stratification and treatment efficacy in clinical trials are in demand. We have recently described a cost-effective non-invasive assay to determine the immune status of glioblastoma patients. Profiling antitumor serum antibodies by customized printed peptide arrays identified response against a tenascin-C (TNC) peptide as a robust prognostic biomarker
%K Antibodies
%K glioblastoma
%K long-term survival
%K non-invasive
%K biomarker
%K serum
%K TNC
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801449/